​

Hinge Health (HNGE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HNGE Stock Forecast

Hinge Health (HNGE) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $100.85, with a high of $125.00 and a low of $76.00. This represents a 9.29% increase from the last price of $92.28.

HNGE Stock Rating

Hinge Health stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (93.75%), 1 Hold (6.25%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 1 15 Strong Sell Sell Hold Buy Strong Buy

HNGE Price Target Upside V Benchmarks

TypeNameUpside
StockHinge Health9.29%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 19.22%

Price Target Trends

1M3M12M
# Anlaysts21345
Avg Price Target$102.50$104.08$78.38
Last Closing Price$92.28$92.28$92.28
Upside/Downside11.07%12.79%-15.06%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26781--16
Aug, 26781--16
Jul, 26781--16
Jun, 26781--16
May, 26781--16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 22, 2026Robert W. Baird$90.00$94.45-4.71%-2.47%
Sep 08, 2026David GrossmanStifel Nicolaus$115.00$92.3724.50%24.62%
Aug 10, 2026Jailendra SinghTruist Financial$112.00$91.6622.19%21.37%
Aug 05, 2026Elizabeth AndersonEvercore ISI$105.00$84.9123.66%13.78%
Aug 05, 2026Rishi JaluriaRBC Capital$110.00$79.4238.50%19.20%
Aug 05, 2026Richard CloseCanaccord Genuity$105.00$79.4232.21%13.78%
Aug 05, 2026David GrossmanStifel Nicolaus$96.00$79.4220.88%4.03%
Aug 05, 2026Barclays$100.00$79.4225.91%8.37%
Jul 27, 2026Stifel Nicolaus$90.00$74.3121.11%-2.47%
Jul 21, 2026Canaccord Genuity$100.00$87.7014.03%8.37%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 05, 2026Evercore ISIOutperformOutperformhold
Aug 05, 2026RBC CapitalOutperformOutperformhold
Aug 05, 2026BarclaysOverweightOverweighthold
Jul 27, 2026CitigroupOutperformOutperformhold
Jul 13, 2026Morgan StanleyOverweightOverweighthold
Jul 13, 2026BarclaysOverweightOverweighthold
Jul 13, 2026KeyBancOverweightOverweighthold
Jun 23, 2026Wells FargoOverweightOverweighthold
Jun 15, 2026Raymond JamesOutperformOutperformhold
Jun 12, 2026KeyBancOverweightOverweighthold

Financial Forecast

EPS Forecast

$-25 $-19 $-13 $-7 $-1 $5 Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$-0.15$-5.36--
Avg Forecast$-19.47$1.04$1.16$0.13
High Forecast$-18.84$1.27$1.39$0.58
Low Forecast$-20.16$0.55$0.76$-0.17
Surprise %-99.23%-615.38%--

Revenue Forecast

$350M $440M $530M $620M $710M $800M Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$390.40M$587.86M--
Avg Forecast$480.79M$551.14M$650.51M$776.23M
High Forecast$493.85M$555.10M$671.40M$797.31M
Low Forecast$468.89M$549.00M$612.50M$757.01M
Surprise %-18.80%6.66%--

Net Income Forecast

$-2B $-2B $-1B $-500M $0 $500M Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$-11.93M$-528.26M--
Avg Forecast$-1.52B$70.99M$83.87M$21.00M
High Forecast$-1.47B$99.08M$108.44M$45.25M
Low Forecast$-1.57B$42.91M$59.29M$-13.26M
Surprise %-99.22%-844.09%--

HNGE Forecast FAQ

Is Hinge Health stock a buy?

Hinge Health stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Hinge Health is a favorable investment for most analysts.

What is Hinge Health's price target?

Hinge Health's price target, set by 16 Wall Street analysts, averages $100.85 over the next 12 months. The price target range spans from $76 at the low end to $125 at the high end, suggesting a potential 9.29% change from the previous closing price of $92.28.

How does Hinge Health stock forecast compare to its benchmarks?

Hinge Health's stock forecast shows a 9.29% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the healthcare information services stocks industry (19.22%).

What is the breakdown of analyst ratings for Hinge Health over the past three months?

  • September 2026: 43.75% Strong Buy, 50.00% Buy, 6.25% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 43.75% Strong Buy, 50.00% Buy, 6.25% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 43.75% Strong Buy, 50.00% Buy, 6.25% Hold, 0% Sell, 0% Strong Sell.

What is Hinge Health’s EPS forecast?

Hinge Health's average annual EPS forecast for its fiscal year ending in December 2026 is $1.16, marking a -121.64% decrease from the reported $-5.36 in 2025. Estimates for the following years are.

What is Hinge Health’s revenue forecast?

Hinge Health's average annual revenue forecast for its fiscal year ending in December 2026 is $650.51M, reflecting a 10.66% increase from the reported $587.86M in 2025. The forecast for.

What is Hinge Health’s net income forecast?

Hinge Health's net income forecast for the fiscal year ending in December 2026 stands at $83.87M, representing a -115.88% decrease from the reported $-528M in 2025. Projections indicate .